GOLDSMITH MARK A 4
4 · Revolution Medicines, Inc. · Filed Dec 18, 2025
Insider Transaction Report
Form 4
GOLDSMITH MARK A
DirectorSee Remarks
Transactions
- Sale
Common Stock
2025-12-16$76.82/sh−15,394$1,182,526→ 232,469 total
Holdings
- 67,424(indirect: By Trust)
Common Stock
- 570,050(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
- [F2]Includes 168,763 restricted stock units.
- [F3]Held by Jonathan Goldsmith Revocable Trust.
- [F4]Held by Rebecca Goldsmith Revocable Trust.
- [F5]Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.